Literature DB >> 29574231

Reduced pupil dilation during action preparation in schizophrenia.

Katharine N Thakkar1, Jan W Brascamp2, Livon Ghermezi2, Kassidy Fifer2, Jeffrey D Schall3, Sohee Park4.   

Abstract

Impairments in cognitive control-the ability to exert control over thoughts and actions and respond flexibly to the environment-are well-documented in schizophrenia. However, the degree to which experimental task performance reflects true cognitive control impairments or more general alterations in effort, arousal and/or task preparedness is unclear. Pupillary responses can provide insight into these latter factors, as the pupil dilates with degree of cognitive effort and response preparation. In the current study, 16 medicated outpatients with schizophrenia (SZP) and 18 healthy controls performed a task that measures the ability to reactively inhibit and modify a planned action-the double-step task. In this task, participants were required to make a saccade to a visual target. Infrequently, the target jumped to a new location and participants were instructed to rapidly inhibit and change their eye movement plan. Applying a race model of performance, we have previously shown that SZP require more time to inhibit a planned action. In the current analysis, we measured pupil dilation associated with task preparation and found that SZP had a shallower increase in pupil size prior to the onset of the trial. Additionally, reduced magnitude of the pupil response was associated with negative symptom severity in patients. Based on primate neurophysiology and cognitive neuroscience work, we suggest that this blunted pupillary response may reflect abnormalities in a general orienting response or reduced motivational significance of a cue signifying the onset of a preparatory period and that these abnormalities might share an autonomic basis with negative symptoms.
Copyright © 2018 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Cognitive control; Eye movements; Pupillometry; Schizophrenia

Mesh:

Year:  2018        PMID: 29574231      PMCID: PMC5960624          DOI: 10.1016/j.ijpsycho.2018.03.012

Source DB:  PubMed          Journal:  Int J Psychophysiol        ISSN: 0167-8760            Impact factor:   2.997


  53 in total

1.  Lateralized deficit of response inhibition in early-onset schizophrenia.

Authors:  Mark A Bellgrove; Christopher D Chambers; Alasdair Vance; Nicole Hall; Mary Karamitsios; John L Bradshaw
Journal:  Psychol Med       Date:  2005-12-12       Impact factor: 7.723

2.  Dimensional structure of psychotic symptoms: an item-level analysis of SAPS and SANS symptoms in psychotic disorders.

Authors:  V Peralta; M J Cuesta
Journal:  Schizophr Res       Date:  1999-07-27       Impact factor: 4.939

3.  Impairments in executive functioning in patients with remitted and non-remitted schizophrenia.

Authors:  Da Young Yun; Samuel Suk-Hyun Hwang; Yeni Kim; Young Ho Lee; Yong-Sik Kim; Hee Yeon Jung
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2011-04-03       Impact factor: 5.067

4.  Oculomotor and pupillometric indices of pro- and antisaccade performance in youth-onset psychosis and attention deficit/hyperactivity disorder.

Authors:  Canan Karatekin; Christopher Bingham; Tonya White
Journal:  Schizophr Bull       Date:  2009-05-08       Impact factor: 9.306

5.  Easier tasks can have higher processing loads: task difficulty and cognitive resource limitations in schizophrenia.

Authors:  Scott C Fish; Eric Granholm
Journal:  J Abnorm Psychol       Date:  2008-05

6.  Executive "brake failure" following deactivation of human frontal lobe.

Authors:  Christopher D Chambers; Mark A Bellgrove; Mark G Stokes; Tracy R Henderson; Hugh Garavan; Ian H Robertson; Adam P Morris; Jason B Mattingley
Journal:  J Cogn Neurosci       Date:  2006-03       Impact factor: 3.225

7.  Pupil diameter covaries with BOLD activity in human locus coeruleus.

Authors:  Peter R Murphy; Redmond G O'Connell; Michael O'Sullivan; Ian H Robertson; Joshua H Balsters
Journal:  Hum Brain Mapp       Date:  2014-02-07       Impact factor: 5.038

8.  Negative symptoms of schizophrenia are associated with abnormal effort-cost computations.

Authors:  James M Gold; Gregory P Strauss; James A Waltz; Benjamin M Robinson; Jamie K Brown; Michael J Frank
Journal:  Biol Psychiatry       Date:  2013-02-07       Impact factor: 13.382

Review 9.  Chlorpromazine equivalent doses for the newer atypical antipsychotics.

Authors:  Scott W Woods
Journal:  J Clin Psychiatry       Date:  2003-06       Impact factor: 4.384

10.  Transient Pupil Dilation after Subsaccadic Microstimulation of Primate Frontal Eye Fields.

Authors:  Sebastian J Lehmann; Brian D Corneil
Journal:  J Neurosci       Date:  2016-03-30       Impact factor: 6.167

View more
  4 in total

1.  Schizophrenia and the retina: Towards a 2020 perspective.

Authors:  Steven M Silverstein; Samantha I Fradkin; Docia L Demmin
Journal:  Schizophr Res       Date:  2019-11-07       Impact factor: 4.939

2.  Schizophrenia in Translation: Why the Eye?

Authors:  Steven M Silverstein; Joy J Choi; Kyle M Green; Kristen E Bowles-Johnson; Rajeev S Ramchandran
Journal:  Schizophr Bull       Date:  2022-06-21       Impact factor: 7.348

3.  Identification of attention-deficit hyperactivity disorder based on the complexity and symmetricity of pupil diameter.

Authors:  Sou Nobukawa; Aya Shirama; Tetsuya Takahashi; Toshinobu Takeda; Haruhisa Ohta; Mitsuru Kikuchi; Akira Iwanami; Nobumasa Kato; Shigenobu Toda
Journal:  Sci Rep       Date:  2021-04-19       Impact factor: 4.379

4.  Pupillometric Complexity and Symmetricity Follow Inverted-U Curves Against Baseline Diameter Due to Crossed Locus Coeruleus Projections to the Edinger-Westphal Nucleus.

Authors:  Sou Nobukawa; Aya Shirama; Tetsuya Takahashi; Toshinobu Takeda; Haruhisa Ohta; Mitsuru Kikuchi; Akira Iwanami; Nobumasa Kato; Shigenobu Toda
Journal:  Front Physiol       Date:  2021-02-11       Impact factor: 4.566

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.